Skip to main content

Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register
WEBINAR | Mastering B-cell biomarker tracking in autoimmune therapy 10 days 17 hours 25 mins 14 secs SAVE YOUR SEAT!

Infographic: HRMS in DMPK

28 Nov 2019
General interest

As part of our Spotlight on HRMS, we carried out a survey to gain an insight into the trends, challenges and developments associated with the use of HRMS for DMPK studies. We would like to thank everyone who was able to share their thoughts by taking part in the survey – you can see the results below in our infographic.

HRMS in DMPK spotlight infographic_NM-01-min

< Back to – Spotlight: HRMS in DMPK

Top content

  • How blockchain and AI are transforming data integrity in bioanalysis
  • Onsite media partners confirmed for PharmSci 360 2025
  • Novartis to acquire Avidity Biosciences in $12B deal to boost RNA therapeutics pipeline

Related tags

DMPK HRMS infographic QQQ Survey
Previous article Next article

Related articles

10 JUN 2022 NEWS
New HRMS instruments, software and product enhancements unveiled by Waters
24 AUG 2016 SPORTS DRUG TESTING
Q&A With Monica Mazzarino & Franscisco Radler on key anti-doping issues
23 OCT 2019 DRUG DEVELOPMENT
High-resolution mass spectrometry: an essential tool for DMPK studies of novel peptide-based modalities
7 OCT 2019 GENERAL INTEREST
HRMS peptide and protein bioanalysis boot camp
7 OCT 2019 GENERAL INTEREST
HRMS in DMPK: an interview with Szabolcs Szarka
2 MAR 2018 EXPERT OPINION
Ask the Experts: Ian Edwards
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 Bioanalysis Zone